> Home > Investors > Annual Review 2007 > Chairman's letter > JP tribute

JP tribute

The AGM sees the retirement of our Chief Executive Officer JP Garnier, who has served GSK with great style and distinction since the merger in December 2000. JP brought wit, wisdom and hugely impressive business acumen to his role. He was directly responsible for many of the innovations of the last seven years, including the introduction of our Centres of Excellence in Drug Discovery, which have transformed the way we approach R&D, and driving a renewed focus and energy behind our vaccines business. Thank you, JP, on behalf of the Board and the stakeholders of GSK.

line
Picture of JP Garnier laying the foundation stone to extend the flu vaccine site in Dresden, Germany.
Picture of JP Garnier meeting employees at the Notre-Dame de Bondeville GMS site, France.
Picture of JP Garnier presenting at the Pediarix vaccine launch, Nashville.
Picture of JP Garnier at the opening of the Hammersmith Hospital, London.
Laying the foundation stone to extend the flu vaccine site in Dresden, Germany. Meeting employees at the Notre-Dame de Bondeville GMS site, France. Presenting at the Pediarix vaccine launch, Nashville. Opening of the Clinical Imaging Centre, Hammersmith Hospital, London.
Picture of JP Garnier conducting a royal visit to the GSK Biologicals site at Wavre, Belgium.
Picture of JP Garnier visiting a lymphatic filariasis programme in Ghana.
Picture of JP Garnier breaking ground at the new state of the art data centre, Pennsylvania.
Picture of JP Garnier meeting President Bush to discuss pandemic flu vaccination
Conducting a royal visit to the GSK Biologicals site at Wavre, Belgium. Visiting a lymphatic filariasis programme in Ghana. Breaking ground at the new state of the art data centre, Pennsylvania. Meeting President Bush to discuss pandemic flu vaccination.
line

 

image